GE HealthCare Technologies Inc. announced its acquisition of Sofie Biosciences for $945 million.
GE HealthCare Technologies Inc. is making headlines with its announcement to acquire Sofie Biosciences for $945 million. This move aims to integrate its radiopharmaceutical portfolio, according to analysts at Needham. The acquisition comes as GE HealthCare's stock is trading at US$65.29, reflecting a 2.26% increase for the day and a 20.51% decline year-to-date.
Investor takeaway: Investors should watch how this acquisition affects GE HealthCare's market position and financial performance in the radiopharmaceutical sector.
Advertisement
GE HealthCare Technologies Inc.
GEHC.US
GEHC.US
GE HealthCare Technologies Inc.
WealthAwesomeMarket cap
$29.69B
P/E
15.1x
Div. yield
0.22%
Div. / share
$0.14
52W high
$89.64
52W low
$58.72
1W change
-1.56%
Beta
0.85
Analyst Price Targets
Based on 20 analysts covering GEHC · as of Oct 5, 2026
Wall Street analysts forecast GEHC stock price to rise 26.3% over the next 12 months.
Consensus
Buy4.25 / 5.00
Avg. Target
C$83.05
+26.3% Upside
Current Price
C$65.74
Last close
Analyst Breakdown (20 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
19.5%
Annualized
90-Day Vol
34.6%
Annualized
Trend (90d)
+6.9%
Annualized drift
90d Mean
C$67.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$66.28 | C$61.97 – C$70.90 |
| 60 trading days | C$66.83 | C$60.77 – C$73.51 |
| 90 trading days | C$67.39 | C$59.98 – C$75.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
$945 Million Acquisition of Sofie Biosciences
This acquisition is a significant investment to strengthen GE HealthCare's market presence.
Bull case
This acquisition allows GE HealthCare to tap into Sofie's expertise in PET radiopharmaceuticals, which could boost revenue in a growing market.
Bear case
However, this substantial investment might strain resources if the expected growth in the radiopharmaceutical sector does not happen as projected.
What Happened
Advertisement
On October 5, 2026, GE HealthCare announced its acquisition of Sofie Biosciences for $945 million. This strategic move aims to enhance GE HealthCare's capabilities in the market for positron emission tomography (PET) radiopharmaceuticals. The acquisition is part of a broader strategy to strengthen its position in a rapidly growing sector.
What the Numbers Show
After the announcement, GE HealthCare's stock closed at US$65.29, up 2.26% for the day. The trading volume was 1,018,966 shares, slightly below the 20-day average of 3,682,965 shares, indicating cautious trading among investors. Year-to-date, the stock has declined by 20.51%. The company has a P/E ratio of 15.11, with an average analyst target of US$83.05, suggesting a potential upside of 27.2% from the current price.
What to Watch Next
Investors should monitor how the integration of Sofie Biosciences affects GE HealthCare's financial performance in the upcoming quarters. The stock is currently 5.0% below its 50-day moving average of US$68.72 and 8.4% below its 200-day moving average of US$71.28, indicating potential challenges in regaining momentum. Additionally, the stock is trading within 21% of its 52-week range of US$58.72 to US$89.64, suggesting fluctuations ahead as the market reacts to the acquisition.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
